Search

everythinglearnresearchcommunity

for

Search:↓

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

The combination treatment showed a higher response rate but no significant survival benefits.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Removing a cat's pancreatic cancer can temporarily reverse hair loss caused by the disease.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Some cats with sudden hair loss and tiredness might have cancer-related alopecia.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.